WJA
MRK icon

Willis Johnson & Associates’s Merck MRK Stock Holding History

Willis Johnson & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,765
Closed -$232K – 192
2025
Q3 		$232K Buy
+2,765
New +$228K 0.01% 163
2024
Q4 		– Sell
-2,616
Closed -$297K – 169
2024
Q3 		$297K Buy
2,616
+280
+12% +$33.3K 0.02% 124
2024
Q2 		$289K Buy
2,336
+301
+15% +$38.8K 0.02% 127
2024
Q1 		$268K Buy
+2,035
New +$251K 0.02% 122

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Willis Johnson & Associates's MRK Position: Q4 2025 in Review

Willis Johnson & Associates sold out of Merck (MRK) in Q4 2025, closing a stake of 2,765 shares — an estimated $232K sold.

Willis Johnson & Associates first reported a position in MRK in Q1 2024 and held it in 4 quarters. The position peaked at $297K in Q3 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Willis Johnson & Associates reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Willis Johnson & Associates sold 2,765 Merck shares in Q4 2025, an estimated $232K.
  • Willis Johnson & Associates first reported a position in Merck in Q1 2024 and held it in 4 quarters.
  • Willis Johnson & Associates's Merck position peaked at $297K in Q3 2024.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Willis Johnson & Associates's 13F filing for Q4 2025, filed 22 Jan 2026.